Urology
Guideline of guidelines: management of recurrent urinary tract infections in women.
18 May, 2022 | 10:59h | UTC
RCT: The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy.
18 May, 2022 | 10:49h | UTCThe addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial – The Lancet (link to abstract – $ for full-text)
M-A: Comparison of radiofrequency ablation vs. cryoablation For T1 renal tumors.
18 May, 2022 | 10:25h | UTC
Cohort Study: Survival outcomes associated with cytoreductive nephrectomy in patients with metastatic clear cell renal cell carcinoma.
17 May, 2022 | 10:41h | UTC
Commentary on Twitter
In this cohort study, instrumental variable analysis did not find a survival advantage associated with cytoreductive nephrectomy for patients with metastatic clear cell renal cell carcinoma. https://t.co/iljbmtZW4f
— JAMA Network Open (@JAMANetworkOpen) May 16, 2022
RCT: Effect of robot-assisted radical cystectomy with intracorporeal urinary diversion vs. open radical cystectomy on 90-day morbidity and mortality among patients with bladder cancer.
16 May, 2022 | 02:35h | UTCEditorial: Robotic Surgery for Bladder Cancer – JAMA
Commentary on Twitter
In this trial, robot-assisted surgery vs open surgery for radical cystectomy among patients with #bladdercancer resulted in a statistically significantly greater number of days alive and out of the hospital. https://t.co/icPLiKH0Lf
— JAMA (@JAMA_current) May 15, 2022
European Guidelines on the management of female non-neurogenic lower urinary tract symptoms.
16 May, 2022 | 02:13h | UTC
AUA/SMSNA Guideline: The diagnosis and management of priapism.
13 May, 2022 | 11:08h | UTC
AUA/ASTRO Guideline: Clinically localized prostate cancer.
13 May, 2022 | 11:10h | UTCHomepage: Clinically Localized Prostate Cancer: AUA/ASTRO Guideline – American Urological Association
Part I: Introduction, Risk Assessment, Staging and Risk-Based Management
Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up
Part III: Principles of Radiation and Future Directions
Related:
Therapies for Clinically Localized Prostate Cancer – Agency for Healthcare Research and Quality
Radical prostatectomy versus deferred treatment for localised prostate cancer – Cochrane Library
AUA Guideline: Diagnosis and treatment interstitial cystitis/bladder pain syndrome.
13 May, 2022 | 11:07h | UTC
Review: Assessment and management of cognitive function in patients with prostate cancer treated with second-generation androgen receptor pathway inhibitors.
10 May, 2022 | 10:32h | UTC
RCT: Reloxaliase vs. placebo in enteric hyperoxaluria.
9 May, 2022 | 01:30h | UTCRandomized Placebo-Controlled Trial of Reloxaliase in Enteric Hyperoxaluria – NEJM Evidence
Commentary on Twitter
Patients with enteric hyperoxaluria received reloxaliase, an enzyme that degrades oxalate in the GI tract, or placebo with food for 4 weeks. There was a greater reduction in urinary oxalate excretion with reloxaliase. https://t.co/x7m12QHyWX#NephTwitter #UroSoMe #ClinicalTrials pic.twitter.com/rzCpd6YfLM
— NEJM Evidence (@NEJMEvidence) May 6, 2022
Review: A global approach to improving penile cancer care.
5 May, 2022 | 09:55h | UTCA global approach to improving penile cancer care – Nature Reviews Urology (if the link is paywalled, try this one)
Guideline: Management of small renal masses.
28 Apr, 2022 | 10:36h | UTCSee also: Summary of Recommendations
Review: Germline testing and genetic counselling in prostate cancer.
28 Apr, 2022 | 08:11h | UTCGermline testing and genetic counselling in prostate cancer – Nature Reviews Urology (if the link is paywalled, try this one at PMC)
Podcast: Lower urinary tract symptoms, benign prostatic hyperplasia, and urinary incontinence.
28 Apr, 2022 | 08:00h | UTCLUTS, BPH, and Urinary Incontinence Triple Distilled – The Curbsiders
M-A: Intensification of systemic therapy in addition to definitive local treatment in nonmetastatic unfavorable prostate cancer.
26 Apr, 2022 | 07:51h | UTC
Consensus Statement: Management of patients with advanced prostate cancer.
25 Apr, 2022 | 00:50h | UTC
Commentary on Twitter
Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021https://t.co/GjTGPx8IbN@APCCC_Lugano @Silke_Gillessen @AOmlin @AarmstrongDuke @piet_ost @Prof_IanD @DrSpratticus @charlesryanmd @Tilki_De @declangmurphy pic.twitter.com/FU0Fbjf8WZ
— European Urology (@EUplatinum) April 22, 2022
An observational study suggests coprescription of Phosphodiesterase Type 5 Inhibitors (i.e., sildenafil) and oral Nitrates is not associated with increased risk of adverse cardiovascular outcomes in male patients with ischemic heart disease.
20 Apr, 2022 | 10:11h | UTCCommentaries:
PDE5 Inhibitors Prescribed for Men on Oral Nitrates for IHD – HealthDay
Opinion | Low-grade prostate cancer (Gleason score 6): time to stop calling it cancer.
19 Apr, 2022 | 02:29h | UTCLow-Grade Prostate Cancer: Time to Stop Calling It Cancer – Journal of Clinical Oncology
Commentary: Doctors suggest new names for low-grade prostate cancer – Associated Press
10-year results of a phase 3 RCT: High-dose radiotherapy and risk-adapted androgen deprivation in localized prostate cancer.
19 Apr, 2022 | 01:22h | UTCHigh-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial – The Lancet Oncology (link to abstract – $ for full-text)
Endocrine therapies for breast and prostate cancers: Essentials for primary care.
19 Apr, 2022 | 01:14h | UTC
Systematic review of the incidence of and risk factors for urothelial cancers and renal cell carcinoma among patients with hematuria.
14 Apr, 2022 | 08:16h | UTCSystematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with Haematuria – European Urology (link to abstract – $ for full-text)
Commentary on Twitter
Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with Haematuriahttps://t.co/zB6CHYKprL@stingrai78 @drimranomar @ahmostafid @soukup_viktor @Phil_Violette pic.twitter.com/Ouv3lFfRpm
— European Urology (@EUplatinum) April 11, 2022
Cohort Study: Association of bone mineral density testing with risk of major osteoporotic fractures among older men receiving androgen deprivation therapy to treat localized or regional prostate cancer.
14 Apr, 2022 | 07:59h | UTCCommentary: Men treated for prostate cancer have increased fracture risk, yet few complete DXA screening – HealthImaging
Commentary on Twitter
In this cohort study, osteoporosis screening rates for over 50,000 elderly men with prostate cancer receiving hormonal therapy nationwide were very low; men who were screened were less likely to suffer major fractures in follow-up. https://t.co/RMz1bvEgiA
— JAMA Network Open (@JAMANetworkOpen) April 1, 2022
Systematic Review: Narrow band imaging vs. white light cystoscopy alone for transurethral resection of non‐muscle invasive bladder cancer.
13 Apr, 2022 | 09:36h | UTC
M-A: The clinical effect and safety of new preoperative fasting time guidelines for elective surgery.
12 Apr, 2022 | 09:51h | UTCRelated:
Does my hospitalized patient need an NPO-after-midnight order preoperatively?
Pro-Con Debate: 1- vs 2-Hour Fast for Clear Liquids Before Anesthesia in Children.